Arsenic trioxide and triptolide synergistically induce apoptosis in the SKM-1 human myelodysplastic syndrome cell line

Although certain combination therapies comprising arsenic trioxide (As(2)O(3)) with other agents exist for the treatment of several types of human cancer, few As(2)O(3) combination therapies are clinically effective for myelodysplastic syndromes (MDS). Triptolide (TL) may be an effective therapeutic...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mol Med Rep
Egile Nagusiak: Hua, Hai-Ying, Gao, Hua-Qiang, Sun, Ai-Ning, Cen, Jian-Nong, Wu, Li-Li
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2016
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5101914/
https://ncbi.nlm.nih.gov/pubmed/27665715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2016.5779
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak